GLP-1 warning signs you shouldn’t ignore
Sudden vision loss is a surprising but very uncommon side effect of some GLP-1 drugs, health officials say.
James R. Hood, an editor and consumer-affairs journalist with more than five decades of experience, has held senior editorial leadership roles at The Associated Press, United Press International, Zapnews and ConsumerAffairs.
Sudden vision loss is a surprising but very uncommon side effect of some GLP-1 drugs, health officials say.
AI/Privacy
The United Nations and other governmental bodies are adding to warnings about the safety of loosely controlled AI systems.
AI/Privacy
AI shopping agents could eliminate much of the drudgery of comparing financial products — while quietly creating an extraordinarily powerful new middleman.
AI/Privacy
AI agents will soon be offering to manage your financial affairs in sort of a "self-driving" mode. Is this a good idea?
Money
The Fed's higher interest rate arrives when households are already contending with renewed inflation and extremely expensive revolving debt.
AI/Privacy
AI is becoming a safety issue, not just a free speech issue.
Two serious health-related recalls today - one hospital-centered, the other a "performance enhancer."
* States are beginning to impose special rates, long-term contracts and exit penalties on massive data centers to prevent their costs from being shifted to households. * Oregon, Ohio, Virginia, Michigan and Georgia have adopted some of the clearest protections, while other states are still developing their rules. * Even strong state
Cars
If a dealer advertises a car for $29,995, an ordinary customer should actually be able to buy it for $29,995, plus legitimate government charges.
Recalls
Gas tanks and "immune boosters" lead the recall rundown.
AI/Privacy
AI is coming for your electricity and, now, your natural gas too.
AI/Privacy
The energy grid in the U.S. is under increasing strain and guess who may get stuck with the bill to upgrade it.